Evelo Biosciences Inc.
0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM
0.32
63080.00%
After-hours Dec 11, 2023, 06:46 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -114.53M -122.18M -93.67M -85.47M -56.95M -28.05M -13.33M
Depreciation & Amortization 2.06M 2.22M 2.03M 1.76M 1.94M 834.00K 495.00K
Stock-Based Compensation 15.16M 15.85M 8.47M 8.16M 6.06M 1.54M 419.00K
Other Working Capital -9.84M 1.91M 6.93M 4.06M 1.39M 1.30M 99.00K
Other Non-Cash Items 5.74M 2.10M 2.35M 255.00K 103.00K 35.00K 28.00K
Deferred Income Tax n/a 3.22M -6.00K -166.00K 406.00K 301.00K 20.00K
Change in Working Capital -9.67M 2.07M 7.76M 3.47M 1.16M 2.07M 56.00K
Operating Cash Flow -101.23M -96.72M -73.06M -71.98M -47.28M -23.27M -12.31M
Capital Expenditures -622.00K -1.52M -1.32M -3.03M -5.46M -1.74M -1.25M
Acquisitions n/a n/a n/a n/a n/a n/a 10.49M
Purchase of Investments n/a n/a n/a n/a -136.09M n/a n/a
Sales Maturities Of Investments n/a n/a n/a 55.00M 81.25M n/a n/a
Other Investing Acitivies n/a 38.00K 6.00K 2.00K 171.00K n/a 27.00K
Investing Cash Flow -622.00K -1.48M -1.31M 51.97M -60.13M -1.74M 9.26M
Debt Repayment -3.12M 14.78M 10.00M 4.48M 4.97M n/a 7.00M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 234.00K 1.01M 471.00K 511.00K 81.21M 48.97M 8.74M
Financial Cash Flow 81.66M 97.54M 65.47M 4.99M 162.01M 48.97M 15.74M
Net Cash Flow -20.66M -666.00K -8.91M -15.02M 54.60M 23.96M 12.69M
Free Cash Flow -101.86M -98.24M -74.38M -75.01M -52.74M -25.01M -13.56M

Create Price Alert on EVLO

Your price alert will notify you when the stock price is above 0.00.

Add to Watchlist